GSO ASTM F639:2021

ASTM F639:09(2015)
Gulf Standard   Current Edition · Approved on 01 July 2021

Standard Specification for Polyethylene Plastics for Medical Applications

GSO ASTM F639:2021 Files

English 3 Pages
Current Edition Reference Language

GSO ASTM F639:2021 Scope

This specification covers the properties for polyethylene plastics for use in medical device applications involving human tissue contact devices, short term indwellings, and fluid transfer devices. Biocompatibility tests must be conducted on the final products as the biocompatibility of these materials as a class has not been established. Plyethylene plastics should consist of basic polymers with ethylene as essentially the sole monomer. The compound may contain optional adjuvant substances required in polymer production or fabrication. The final compound should yield a consistent absorption spectrum characteristic of the established formulation. The polyethylene plastics should be tested using the specified physical test procedures for density, melt flow, tensile properties, compressive properties, stiffness, flexural fatigue, and other flexural properties.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 2063:2023
 
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants

Recently Published from Health Sector

GSO ISO 11608-7:2024
ISO 11608-7:2016 
Gulf Standard
Needle-based injection systems for medical use — Requirements and test methods — Part 7: Accessibility for persons with visual impairment
GSO ISO/TR 24666:2024
ISO/TR 24666:2023 
Gulf Standard
Sports and recreational facilities — Probes for entrapment/entanglement on playground equipment — Collection of data
GSO ISO 9713:2024
ISO 9713:2022 
Gulf Standard
Neurosurgical implants — Self-closing intracranial aneurysm clips
GSO ISO/TS 22690:2024
ISO/TS 22690:2021 
Gulf Standard
Genomics informatics — Reliability assessment criteria for high-throughput gene-expression data